XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.40

+0.8%

9:53 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16454)	11/20/2003 12:09:55 AM
From: LarryS	Read Replies (2) of 17367

I wonder if the date DNA/XOMA decided to start selling Raptiva was coordinated with the date of this NEJM article?? And started selling is a misnomer....aren't a bunch of folks already taking this drug, the ones who participated in the trials and requested to continue on Raptiva? Who pays for the drug after a trial is over, DNA/XOMA, the participant or their insurance??

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next